Abstract

BackgroundLangerhans cell histiocytosis (LCH) features inflammatory granuloma characterised by the presence of CD1a+ dendritic cells or ‘LCH cells’. Badalian-Very et al. recently reported the presence of a canonical V600EB-RAF mutation in 57% of paraffin-embedded biopsies from LCH granuloma. Here we confirm their findings and report the identification of two novel B-RAF mutations detected in LCH patients.Methods and ResultsMutations of B-RAF were observed in granuloma samples from 11 out of 16 patients using ‘next generation’ pyrosequencing. In 9 cases the mutation identified was V600EB-RAF. In 2 cases novel polymorphisms were identified. A somatic 600DLATB-RAF insertion mimicked the structural and functional consequences of the V600EB-RAF mutant. It destabilized the inactive conformation of the B-RAF kinase and resulted in increased ERK activation in 293 T cells. The 600DLATB-RAF and V600EB-RAF mutations were found enriched in DNA and mRNA from the CD1a+ fraction of granuloma. They were absent from the blood and monocytes of 58 LCH patients, with a lower threshold of sequencing sensitivity of 1%–2% relative mutation abundance. A novel germ line T599AB-RAF mutant allele was detected in one patient, at a relative mutation abundance close to 50% in the LCH granuloma, blood monocytes and lymphocytes. However, T599AB-RAF did not destabilize the inactive conformation of the B-RAF kinase, and did not induce increased ERK phosphorylation or C-RAF transactivation.ConclusionsOur data confirmed presence of the V600EB-RAF mutation in LCH granuloma of some patients, and identify two novel B-RAF mutations. They indicate that V600EB-RAF and 600DLATB-RAF mutations are somatic mutants enriched in LCH CD1a+ cells and absent from the patient blood. Further studies are needed to assess the functional consequences of the germ-line T599AB-RAF allele.

Highlights

  • Langerhans cell histiocytosis (LCH) is a pediatric granulomatous disease with an incidence of four to eight cases per million children [1,2,3]

  • Our data confirmed presence of the V600EB-RAF mutation in LCH granuloma of some patients, and identify two novel B-RAF mutations. They indicate that V600EB-RAF and 600DLATB-RAF mutations are somatic mutants enriched in LCH CD1a+ cells and absent from the patient blood

  • Further studies are needed to assess the functional consequences of the germ-line T599AB-RAF allele

Read more

Summary

Introduction

Langerhans cell histiocytosis (LCH) is a pediatric granulomatous disease with an incidence of four to eight cases per million children [1,2,3]. LCH lesions feature granulomatous collections of immature CD1a+ langerin/CD207+ DC (‘LCH cells’) presumed to be pathologic [8,9,10], admixed with abundant eosinophils [11], polyclonal T cells including abundant FoxP3+ CD4+ T cells [12], activated macrophages and osteoclast-like multinucleated giant cells [13]. These granuloma are heterogeneous in cellular composition as well as anatomical distribution. We confirm their findings and report the identification of two novel B-RAF mutations detected in LCH patients

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call